Innate Pharma: shareholder dilution and stock pressure
Innate Pharma's shares increased from 24.75 million in 2006 to 111 million today.
Published 1sem1 sourceupdated 4j
Lire en français
≈ 15s
111 million
75 million in 2006 to 111 million today
The fact
Investors question a potential price drop to €1.70.
The company had previously stated no dilutive financing was planned.
Click the link to read an article on the topic: